European researchers have identified 39 proteins that interact with bacterial toxins in infected human cells, amounting to significant progress in understanding bacterial infection sources. The discovery, funded in part by the EU through the 'Interaction proteome' project, may open up new treatment targets for human illnesses in the future. The study is published in the journal Cell Host and Microbe.
Read more ...
Effectiveness of malaria drug varies throughout Africa
An international study of malaria led by researchers in the UK shows that the effectiveness of the widely used anti-malaria drug sulfadoxine may vary widely across Africa because malaria parasites in different parts of the continent have developed different resistance mutations to the drug.
Read more ...
Tobacco gets new, healthy image
Tobacco use triggers a number of common diseases in humans including heart disease and lung cancer. However, a group of scientists from Europe may be tobacco's saving grace. They successfully used genetically modified tobacco plants to generate medicines for a number of autoimmune and inflammatory diseases. The study was part of the Pharma-Planta project, which was funded under the EU's Sixth Framework Programme (FP6) to the tune of EUR 12 million. The study's results were recently published in the open access journal BMC Biotechnology.
Read more ...
Manhattan Research Releases Digital DTC Relevance Rankings
More than 60% of U.S. adults turn to the Internet as a decision support tool in healthcare and disease management, and certain condition groups are more likely to use online health resources than others, according to pharmaceutical and healthcare market research company Manhattan Research. Acne, restless leg syndrome, and cancer patients are among the top ten therapeutic categories adopting eHealth activities, which can range from reading a health-related blog to joining an online patient community.
Read more ...
Robots and scientists thinking together
Scientists in the UK have incorporated artificial intelligence (AI) and a sophisticated set of algorithms into a robot, named Adam, that can develop hypotheses and carry out a whole scientific experimentation cycle. The research, published in the journal Science, paves the way for dramatically increasing the rate of scientific progress.
Read more ...
CAST PHARMA Announces a New Office in Denmark
CAST PHARMA, a premier European 3D pharmaceutical and biomedical animation production company, has announced the opening of the new office in Ballerup, Denmark. This new office will allow Cast Pharma to meet the growing demand in the Northern Europe pharmaceutical market and to improve services to existing clients.
Read more ...
GoOn Research and Development Project Wins Theseus-Mittelstand
Transinsight announced today that the consortium formed with RESprotect, Antikörper-Online, and the Bioinformatics group of Prof. Dr. Michael Schroeder at TU Dresden, has won the Theseus-Mittelstand for R&D project GoOn. Over the next two years, the project - based on the results of Theseus One - will develop praxis-relevant semantic technologies for information handling in the biomedical domain.
Read more ...